Emory Begins Phase 3 Study of Novavax COVID-19 Vaccine
December 31, 2020
December 31, 2020
ATLANTA, Georgia, Dec. 31 (TNSJou) -- Emory University's Woodruff Health Sciences Center issued the following news release:
Emory University is participating in a new Phase 3 vaccine clinical trial for COVID-19. The clinical trial will test the safety and effectiveness of an investigational protein-based vaccine developed by U.S. biotechnology company Novavax, Inc.
Emory administered the first doses of the vaccine to volunteers this week at the Ponce de Leon clinic . . .
Emory University is participating in a new Phase 3 vaccine clinical trial for COVID-19. The clinical trial will test the safety and effectiveness of an investigational protein-based vaccine developed by U.S. biotechnology company Novavax, Inc.
Emory administered the first doses of the vaccine to volunteers this week at the Ponce de Leon clinic . . .